Elisa Alberton Haas

Elisa Alberton Haas

Auto-generated profile, based on publicly available information

Elisa Alberton Haas

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo , Sao Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
EHElisa A Haas
Elisa A Haas
MSMario Saad
Mario Saad
ASAndrey Santos
Andrey Santos
NVNicola Vitulo
Nicola Vitulo
WJWilson José Fernandes Lemos Junior
Wilson José Fernandes Lemos Junior
PLProtasio L Da Luz
Protasio L Da Luz
Gut microbiota profiles are closely related to cardiovascular diseases through mechanisms that include the reported deleterious effects of metabolites, such as trimethylamine N-oxide (TMAO), which have been studied as diagnostic and therapeutic targets. Moderate red wine (RW) consumption is reportedly cardioprotective, possibly by affecting the gut microbiota. To investigate the effects of RW consumption on the gut microbiota, plasma TMAO, and the plasma metabolome in males with documented coronary artery disease (CAD) using a multiomics assessment in a crossover trial. We conducted a randomized, crossover, controlled trial involving 42 males (average age, 60 years) with documented CAD comparing 3-week RW consumption (250 mL/day, 5 days/week) with an equal period of alcohol abstention, both preceded by a 2-week washout period. The gut microbiota was analyzed via 16S rRNA high-throughput sequencing. Plasma TMAO was evaluated by liquid chromatography coupled with mass spectrometry (LC-MS/MS). The plasma metabolome of 20 randomly selected participants was evaluated by ultra-high-performance LC-MS/MS. The effect of RW consumption was assessed by individual comparisons using paired tests during the abstention and RW periods. Plasma TMAO did not differ between RW intervention and alcohol abstention, and TMAO levels showed low intraindividual concordance over time, with an intraclass correlation coefficient of 0.049 during the control period. After RW consumption, there was significant remodeling of the gut microbiota, with a difference in beta diversity and predominance of Parasutterella, Ruminococcaceae, several Bacteroides species and Prevotella. Plasma metabolomic analysis revealed significant changes in metabolites after RW consumption, consistent with improved redox homeostasis. Modulation of the gut microbiota may contribute to the putative cardiovascular benefits of moderate RW consumption. The low intraindividual concordance of TMAO presents challenges regarding its role as a cardiovascular risk biomarker at the individual level. This study was registered at clinical trials.gov, NCT03232099.

7 July 2020 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Open access
PDF file
PLProtásio L. da Luz
Protásio L. da Luz
EHElisa Alberton Haas
Elisa Alberton Haas
DFDesiderio Favarato
Desiderio Favarato
Recently, gut microbiota has emerged as an important mediator of several diseases such as diabetes, atherosclerosis, arterial hypertension, obesity, cancers and neuropsychiatric diseases including Alzheimer, autism and depression. Intestinal microbiota is formed by bacteria, fungi and viruses and its main function is to facilitate the absorption and metabolism of foods (protein, fat and carbohydrate). One example of the multiple actions of the gut microbiota is the bidirectional relationship between the intestine and the brain, the so-called “gut/brain axis”. Furthermore, metabolites produced by gut microbiota can induce effects locally or at distance, which suggests that the intestine is an endocrine organ. Given the participation of the gut microbiota in several diseases, there is great interest in strategies that may positively affect the gut flora and prevent or even treat diseases. Among these strategies, lifestyle change, but specially diet modulation has gained importance. In this article, we review the mechanisms through which intestinal microbiota participates in cardiovascular diseases and possible therapeutic interventions.